Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 96

    1.

    Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.

    Nigam N, Hedaya J, Freeman WR.

    Br J Ophthalmol. 2008 Jun;92(6):864-5; author reply 865-6. No abstract available. PMID: 18523095 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

    Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

    Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

    3.

    Choroidal neovascularization secondary to Sorsby fundus dystrophy treated with systemic bevacizumab (Avastin).

    Prager F, Michels S, Geitzenauer W, Schmidt-Erfurth U.

    Acta Ophthalmol Scand. 2007 Dec;85(8):904-6. Epub 2007 Apr 13.PMID: 17433023 [PubMed - indexed for MEDLINE]Related articles

    4.

    The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).

    Derriman L, Marshall J, Moorman C, Downes SM.

    Retina. 2008 Jun;28(6):910; author reply 910-1. No abstract available. PMID: 18536613 [PubMed - indexed for MEDLINE]Related articles

    5.

    Intravitreal bevacizumab (Avastin) for the treatment of bilateral acquired juxtafoveal retinal telangiectasis associated with choroidal neovascular membrane.

    Ruys J, De Laey JJ, Vanderhaeghen Y, Van Aken EH.

    Eye (Lond). 2007 Nov;21(11):1433-4. Epub 2007 Aug 10. No abstract available. PMID: 17693997 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Bevacizumab (Avastin) in treatment of choroidal neovascularization secondary to age-related macular degeneration: a case report]

    Faria e Arantes TE, Nascimento VP, Maia OO Jr, Takahashi WY.

    Arq Bras Oftalmol. 2007 Nov-Dec;70(6):1016-20. Portuguese. PMID: 18235918 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Intravitreal bevacizumab (Avastin) iniections for neovascular age-related macular degeneration (AMD)--preliminary results]

    Mackiewicz J, Mańkowska A, Dolar-Szczasny J, Zubilewicz A, Oleszczuk A, Nowomiejska K, Rejdak R, Zagórski Z.

    Klin Oczna. 2007;109(4-6):146-9. Polish. PMID: 17725273 [PubMed - indexed for MEDLINE]Related articles

    8.

    A prospective study on intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration of different durations.

    Algvere PV, Steén B, Seregard S, Kvanta A.

    Acta Ophthalmol. 2008 Aug;86(5):482-9. Epub 2007 Dec 14.PMID: 18162062 [PubMed - indexed for MEDLINE]Related articles

    9.

    Intravitreal bevacizumab (Avastin) in combination with verteporfin photodynamic therapy for choroidal neovascularization associated with age-related macular degeneration (IBeVe Study).

    Costa RA, Jorge R, Calucci D, Melo LA Jr, Cardillo JA, Scott IU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Sep;245(9):1273-80. Epub 2007 Feb 28.PMID: 17333238 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

    Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

    11.

    Ranibizumab for treatment of choroidal neovascularization secondary to age-related macular degeneration.

    Bhatnagar P, Spaide RF, Takahashi BS, Peragallo JH, Freund KB, Klancnik JM Jr, Cooney MJ, Slakter JS, Sorenson JA, Yannuzzi LA.

    Retina. 2007 Sep;27(7):846-50.PMID: 17891007 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

    Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

    Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

    13.

    Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

    Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

    Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks.

    Apte RS.

    Eye (Lond). 2008 May;22(5):734-5. Epub 2008 Mar 14. No abstract available. PMID: 18344971 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal bevacizumab for treatment of choroidal neovascularization in pathologic myopia.

    Tewari A, Dhalla MS, Apte RS.

    Retina. 2006 Nov-Dec;26(9):1093-4. No abstract available. PMID: 17151505 [PubMed - indexed for MEDLINE]Related articles

    16.

    Treatment of choroidal neovascularization using intravitreal bevacizumab.

    Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

    Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

    17.

    Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).

    Ahmadieh H, Vafi N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Nov;245(11):1731-3. Epub 2007 Jul 25.PMID: 17653753 [PubMed - indexed for MEDLINE]Related articles

    18.

    Bevacizumab (avastin) and ranibizumab (lucentis) for choroidal neovascularization in multifocal choroiditis.

    Fine HF, Zhitomirsky I, Freund KB, Barile GR, Shirkey BL, Samson CM, Yannuzzi LA.

    Retina. 2009 Jan;29(1):8-12.PMID: 18784620 [PubMed - indexed for MEDLINE]Related articles

    19.

    The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy.

    Ghajarnia M, Kurup S, Eller A.

    Semin Ophthalmol. 2007 Apr-Jun;22(2):127-31.PMID: 17564935 [PubMed - indexed for MEDLINE]Related articles

    20.

    Thirty-two month follow-up of successful treatment of choroidal neovascularization from angioid streaks with intravitreal bevacizumab.

    Kovach JL, Schwartz SG, Hickey M, Puliafito CA.

    Ophthalmic Surg Lasers Imaging. 2009 Jan-Feb;40(1):77-9.PMID: 19205505 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data